Compare COYA & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COYA | BYFC |
|---|---|---|
| Founded | 2020 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.7M | 90.3M |
| IPO Year | 2022 | 2013 |
| Metric | COYA | BYFC |
|---|---|---|
| Price | $5.05 | $11.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.21 | N/A |
| AVG Volume (30 Days) | ★ 130.8K | 1.3K |
| Earning Date | 11-11-2026 | 07-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $7,945,753.00 | $184,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $387.14 | N/A |
| P/E Ratio | ★ N/A | $171.21 |
| Revenue Growth | ★ 123.57 | 18.71 |
| 52 Week Low | $3.71 | $5.51 |
| 52 Week High | $7.75 | $12.35 |
| Indicator | COYA | BYFC |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 57.95 |
| Support Level | $4.42 | $11.76 |
| Resistance Level | $5.17 | $12.33 |
| Average True Range (ATR) | 0.28 | 0.08 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 62.75 | 59.09 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank offers a variety of commercial real estate loan products, services, and depository accounts that support investments in affordable housing, small businesses, and nonprofit community facilities located within low-to-moderate income neighborhoods.